Willie Muehlhausen

Partner, Digital Innovator
SAFIRA Clinical Research, Ireland
Willie Co-founded SAFIRA 2021 after spending more than 20 years in the clinical research industry working for CROs and technology companies in Germany, UK, US and Ireland. He served as the inaugural Vice-Director of the C-Path ePRO Consortium shaping the initial work of the founding members and is an active member in DIA, ISPOR and DIME research groups. In recent years he initiated and directed research on multiple patient-facing technologies (i.e. ePRO / BYOD, Wearables, Patient Burden, Fraud Detection via Machine Learning) and co-authored more than 40 publications and two books on electronic Patient Reported Outcomes. Willie successfully developed multiple product and service lines in the eCOA space including the first dedicated ePRO Management group within a global CRO. His work has been recognized by his industry peers by including him in the PharmaVoice100 in 2015 and the CenterWatch Top 20 Innovators in 2018. Willie provides independent eClinical commentary via Linkedin (https://www.linkedin.com/in/williemuehlhausen/) and X (@WMePRO).

Events/Masterclasses Willie Muehlhausen is currently speaking at

Pharma

Digital Quality in Clinical Trials
22 – 23 April 2026
Vienna, Austria
With the increasing complexity of today’s clinical trials, as well as the speed of technological innovation and AI tools utilization, unique issues remain especially around clinical trials and the use of electronic systems.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Willie Muehlhausen
Partner, Digital Innovator
SAFIRA Clinical Research, Ireland
Willie Co-founded SAFIRA 2021 after spending more than 20 years in the clinical research industry working for CROs and technology companies in Germany, UK, US and Ireland. He served as the inaugural Vice-Director of the C-Path ePRO Consortium shaping the initial work of the founding members and is an active member in DIA, ISPOR and DIME research groups. In recent years he initiated and directed research on multiple patient-facing technologies (i.e. ePRO / BYOD, Wearables, Patient Burden, Fraud Detection via Machine Learning) and co-authored more than 40 publications and two books on electronic Patient Reported Outcomes. Willie successfully developed multiple product and service lines in the eCOA space including the first dedicated ePRO Management group within a global CRO. His work has been recognized by his industry peers by including him in the PharmaVoice100 in 2015 and the CenterWatch Top 20 Innovators in 2018. Willie provides independent eClinical commentary via Linkedin (https://www.linkedin.com/in/williemuehlhausen/) and X (@WMePRO).
Willie Muehlhausen
Description